Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis

Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis

Hareer Fatima,1 Hussain Sohail Rangwala,1 Muhammad Saqlain Mustafa,1 Muhammad Ashir Shafique,1 Syed Raza Abbas,2 Azra Rizwan,3 Tagwa Kalool Fadlalla Ahmed,4 Ainan Arshad3 1Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan; 2Department of Medicine, Dow University of Health Sc...

Full description

Bibliographic Details
Main Authors: Fatima H, Rangwala HS, Mustafa MS, Shafique MA, Abbas SR, Rizwan A, Fadlalla Ahmed TK, Arshad A
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
diabetes mellitus
glucagon-like peptide 1 receptor agonists
danuglipron
adverse outcomes
glycemic parameters
Online Access:https://www.dovepress.com/evaluating-glycemic-control-efficacy-and-safety-of-the-oral-small-mole-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/evaluating-glycemic-control-efficacy-and-safety-of-the-oral-small-mole-peer-reviewed-fulltext-article-DMSO

Similar Items